• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. International Journal of Biological Chemistry
  2. Vol 3 (1), 2009
  3. 30-34
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

International Journal of Biological Chemistry

Year: 2009 | Volume: 3 | Issue: 1 | Page No.: 30-34

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 928

Search


Authors


A. Vijaya Anand

Country: India

M. Chandrasekharan

Country: India

S. Kalavathy

Country: India

K. Uma

Country: India

M.P. Saravanan

Country: India

A. Mohamed Saleem Gani

Country: India

K. Vijaya Kumar

Country: India

R. Senthil

Country: India

P. Sampath Kumar

Country: India

Keywords


  • statin
  • CRP
  • Vascular disease
  • inflammation
  • hyperlipemic
Research Article

The Influencing Aspects of Atorvastatin on C-Reactive Protein and Lipid Profile in Patients with Stroke

A. Vijaya Anand, M. Chandrasekharan, S. Kalavathy, K. Uma, M.P. Saravanan, A. Mohamed Saleem Gani, K. Vijaya Kumar, R. Senthil and P. Sampath Kumar
The present study was designed to determine the effects of atorvastatin on C-Reactive Protein (CRP) and lipid profile in patients with stroke, since their anti-inflammatory properties have been investigated recently. Ninety five patients with or without stroke were recruited for the study, of which 60 belongs to control (untreated) and 35 were test group (treated) and received daily with 10 mg day-1 of atorvastatin. The patients were followed for over a period of 3 months. For entire study population, CRP along with lipid profile, Serum Glutamic Oxaloacetic Transaminase (SGOT) and Serum Glutamic Pyruvic Transaminase (SGPT) were measured 1st day and at the end of 3rd month of the treatment. Treatment with atorvastatin decreases both inflammatory activity and atherogenic lipoproteins. The results of this study will provide important information on how to maximize the therapeutic benefits of atorvastatin in a broader range of patients at risk for cerebrovascular morbidity and mortality.
PDF Fulltext XML References Citation

How to cite this article

A. Vijaya Anand, M. Chandrasekharan, S. Kalavathy, K. Uma, M.P. Saravanan, A. Mohamed Saleem Gani, K. Vijaya Kumar, R. Senthil and P. Sampath Kumar, 2009. The Influencing Aspects of Atorvastatin on C-Reactive Protein and Lipid Profile in Patients with Stroke. International Journal of Biological Chemistry, 3: 30-34.

URL: https://scialert.net/abstract/?doi=ijbc.2009.30.34

Related Articles